Equity Analysis /
United States of America

US : Gilead Sciences, Inc. - GILD | Long-Term Yescarta Outlook Improved Exiting ASH 2021

    Contributors
    Timur Ivannikov
    Ryan Deschner
    CGS-CIMB
    14 December 2021
    Published by